Target-directed MicroRNA Degradation: Mechanisms, Significance, and Functional Implications
Overview
Affiliations
MicroRNAs (miRNAs) are small non-coding RNAs that play a fundamental role in enabling miRNA-mediated target repression, a post-transcriptional gene regulatory mechanism preserved across metazoans. Loss of certain animal miRNA genes can lead to developmental abnormalities, disease, and various degrees of embryonic lethality. These short RNAs normally guide Argonaute (AGO) proteins to target RNAs, which are in turn translationally repressed and destabilized, silencing the target to fine-tune gene expression and maintain cellular homeostasis. Delineating miRNA-mediated target decay has been thoroughly examined in thousands of studies, yet despite these exhaustive studies, comparatively less is known about how and why miRNAs are directed for decay. Several key observations over the years have noted instances of rapid miRNA turnover, suggesting endogenous means for animals to induce miRNA degradation. Recently, it was revealed that certain targets, so-called target-directed miRNA degradation (TDMD) triggers, can "trigger" miRNA decay through inducing proteolysis of AGO and thereby the bound miRNA. This process is mediated in animals via the ZSWIM8 ubiquitin ligase complex, which is recruited to AGO during engagement with triggers. Since its discovery, several studies have identified that ZSWIM8 and TDMD are indispensable for proper animal development. Given the rapid expansion of this field of study, here, we summarize the key findings that have led to and followed the discovery of ZSWIM8-dependent TDMD. This article is categorized under: Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs RNA Turnover and Surveillance > Turnover/Surveillance Mechanisms RNA in Disease and Development > RNA in Development.
Hiers N, Li L, Li T, Sheng P, Wang Y, Traugot C bioRxiv. 2024; .
PMID: 39713366 PMC: 11661237. DOI: 10.1101/2024.12.11.627053.
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.
Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M Cancer Cell Int. 2024; 24(1):410.
PMID: 39702293 PMC: 11660508. DOI: 10.1186/s12935-024-03596-8.
Gao B, Wang L, Wen T, Xie X, Rui X, Chen Q Int J Mol Sci. 2024; 25(21).
PMID: 39518984 PMC: 11545876. DOI: 10.3390/ijms252111433.
Perspective on adolescent psychiatric illness and emerging role of microRNAs as biomarkers of risk.
Morgunova A, Teixeira M, Flores C J Psychiatry Neurosci. 2024; 49(4):E282-E288.
PMID: 39209460 PMC: 11374446. DOI: 10.1503/jpn.240072.
Therapeutic targeting of RNA for neurological and neuromuscular disease.
Bubenik J, Scotti M, Swanson M Genes Dev. 2024; 38(15-16):698-717.
PMID: 39142832 PMC: 11444190. DOI: 10.1101/gad.351612.124.